What did @therestoreclinic actually say?
The creator explains that HCG works as a luteinizing hormone mimetic, stimulating what they call "lating cells" (Leydig cells) in the testes to raise intratesticular testosterone, which then spills over to stimulate Sertoli cells and sperm production. They correctly note that HCG does not work for every man on TRT, and that some patients become "refractory" to it over time. For those cases, they suggest adding FSH to directly stimulate Sertoli cells and get a "more robust response." The overall message is measured: HCG is a reasonable first step, but it is not a guaranteed fix. That framing is largely responsible and reflects real clinical experience, even if a few of the anatomical terms got garbled in delivery.
Does the science back this up?
Yes, with important nuance. The core mechanism is solid. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, crashing LH and FSH, which tanks intratesticular testosterone (ITT) and kills spermatogenesis. HCG, as an LH analog, partially restores ITT. Liu et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that low-dose HCG co-administration with testosterone maintained ITT and preserved sperm parameters in most, but not all, subjects. The "refractory" phenomenon the creator mentions is less well-documented in randomized trials, but LH receptor desensitization with chronic HCG exposure is a real pharmacological concern supported by receptor-level studies. On the FSH side, Bhasin et al. (2014, NEJM) and work by Ramasamy et al. (2014, Journal of Urology) confirm that FSH is the more direct driver of spermatogenesis, and combining HCG with recombinant FSH or hMG produces better sperm recovery rates than HCG alone in hypogonadotropic hypogonadism.
What did they get wrong (or right)?
The mechanism explanation is directionally correct but the terminology is a mess. The creator says "human coryonic matopropan" instead of human chorionic gonadotropin, and repeatedly says "lating cells" when they mean Leydig cells. Sertoli cells are called "sertolle cells" throughout. These are not minor cosmetic errors on a health platform with 13,900 viewers. Patients searching these terms will get nowhere. That said, the functional description of the LH-ITT-Sertoli pathway is accurate enough to be useful. The claim that HCG "in most patients does a good job of keeping sperm counts quite well" is plausible but overstated without context. A 2020 systematic review by Crosnoe-Shipley et al. in Translational Andrology and Urology found meaningful variability in outcomes. The creator also never mentions that HCG is not FDA-approved for male fertility preservation on TRT as a primary indication, and access to compounded HCG changed significantly after the FDA withdrew its compounded status in 2020. That omission matters clinically.
What should you actually know?
If you are on TRT and care about fertility, the conversation with your prescriber should cover a few things the video skips. First, baseline semen analysis before starting TRT is the standard of care. Second, the HCG dosing and timing that actually shows up in the literature varies widely, and what works for one patient may not work for another. Third, the regulatory status of HCG has shifted. Compounded HCG was pulled from the market by the FDA in 2020 because it was designated a biological product, and many clinics now use kisspeptin analogs, gonadorelin, or enclomiphene as alternatives. Those are not equivalent to HCG, and substituting them without understanding the difference is a problem. Fourth, if you are actively trying to conceive, a reproductive urologist or fertility specialist should be part of your care team, not just a TRT prescriber. The creator gives a reasonable layperson overview, but it is not a substitute for individualized evaluation.